What is the current market size?

The Sample Preparation Products for Next Generation Sequencing market size was valued at USD 1.2 billion in 2023, driven by advancements in genomic research and clinical diagnostics.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, with increasing demand for high-throughput sequencing applications.

What are the key growth drivers?

Key drivers include rising investments in genomics, expansion of NGS in oncology, and adoption of automated sample preparation workflows to improve accuracy.

What challenges hinder market growth?

High costs of equipment and consumables, along with technical complexities in sample handling, remain significant barriers for widespread adoption.

Which regions are leading the market?

North America dominates the market due to advanced healthcare infrastructure, followed by Europe and the Asia-Pacific region, which shows rapid growth.

Who are the top companies in the market?

Leading companies include Thermo Fisher Scientific, Illumina, and QIAGEN, which focus on innovation and strategic partnerships to strengthen their market position.

What future opportunities exist?

Opportunities lie in emerging markets, integration with AI-driven analytics, and expansion of NGS applications in non-invasive prenatal testing and microbiome research.

How does technology impact the market?

Advancements in microfluidics and automation enhance sample preparation efficiency, reducing error rates and enabling high-volume processing in research and diagnostics.

What is the regulatory landscape?

Regulatory frameworks by the FDA and EMA ensure product compliance, while evolving guidelines for NGS-based diagnostics shape market standards globally.

How is the market adapting to new trends?

The market is adopting single-cell sequencing and liquid biopsy technologies, aligning with trends toward precision medicine and personalized healthcare solutions.

Sample Preparation Products for Next Generation Sequencing Growth Analysis & Future Outlook 2033

Sample Preparation Products for Next Generation Sequencing by Application (Biotechnology, Medical, Pharmatheutical, Others), by Types (DNA Extraction, Purification, and Isolation Products, RNA Extraction, Purification, and Isolation Products, Panels, Exome Kits, and Other Target Enrichment Products, DNA Library Construction/ Preparation Products, RNA-Seq, Transcriptome, and Gene Expression Products, Small RNA NGS Sample Preparation Products), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 89

Forecast Period: 2026 - 2033

Market Size: $3200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 89

Forecast Period: 2026 - 2033

Market Size: $3200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Sample Preparation Products for Next Generation Sequencing Market Size | CAGR 12.8 Forecast 2033

Sample Preparation Products for Next Generation Sequencing Growth Analysis & Future Outlook 2033

🏭 Healthcare🌍 Global

Pages: 89

Forecast Period: 2026 - 2033

Market Size: $3200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 89

Forecast Period: 2026 - 2033

Market Size: $3200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Sample Preparation Products for Next Generation Sequencing Market Overview

The Sample Preparation Products for Next Generation Sequencing (NGS) market encompasses tools, kits, and reagents essential for isolating, purifying, and preparing biological samples for high-throughput genomic analysis. As precision medicine and cancer genomics drive demand for actionable insights, this market plays a pivotal role in enabling advancements in diagnostics, drug discovery, and personalized healthcare. The Sample Preparation Products for Next Generation Sequencing market size is projected to exceed $1.8 billion by 2026, reflecting robust growth outlook and strategic industry expansion. With a compound annual growth rate (CAGR) of 13.2% during 2026–2033, the sector is shaped by cutting-edge innovations, regulatory momentum, and regional disparities in healthcare infrastructure.

Loading chart…

Key macro drivers include the adoption of multi-omics research, rising investments in cancer genomics, and the integration of AI-driven automation in lab workflows. North America dominates the market due to its robust biotech ecosystem, while Asia-Pacific emerges as the fastest-growing region, fueled by expanding healthcare accessibility and government-funded genomics initiatives. Competitive intensity is escalating as major players prioritize R&D partnerships and streamlined supply chains to address the urgent need for high-throughput, cost-effective sample preparation solutions.

Report Overview

Report Attribute	Details
Market size value in 2025	3.20 billion
Revenue forecast in 2033	8.39 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	10X Genomics; Agilent Technologies; F. Hoffmann-La Roche AG; Fluidigm; Illumina; New England Biolabs; Oxford Nanopore; Pacific Biosciences; Qiagen; Thermo Fisher Scientific
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Advancements in genomic research are accelerating the Sample Preparation Products for Next Generation Sequencing market size, driven by increasing adoption of NGS in oncology, rare disease diagnostics, and agricultural genomics. Technological innovations, such as automation and AI-integrated workflows, are improving efficiency and accuracy, fueling demand.

Personalized medicine initiatives and rising cancer incidence rates are propelling investment in NGS sample prep tools, with healthcare providers prioritizing scalable solutions to meet diagnostic and therapeutic needs. This trend is expected to underpin a robust growth forecast through 2030.

Restraints2 items

High costs of sample preparation kits and specialized equipment limit market penetration in emerging economies, where budget constraints and underfunded healthcare systems hinder adoption. This pricing barrier is exacerbated by the need for frequent reagent replacements.

Regulatory complexities in cross-border R&D collaborations and fragmented approval processes slow product commercialization, particularly in regions with stringent compliance requirements for genetic testing workflows.

Opportunities2 items

Expansion into decentralized testing models presents a strategic opportunity, as point-of-care NGS solutions gain traction for rapid infectious disease detection and real-time monitoring in remote settings.

Partnerships between biotech firms and academic institutions are unlocking novel sample prep methods, such as single-cell sequencing and spatialomics, which could redefine standards in precision medicine and unlock new revenue streams in the Sample Preparation Products for Next Generation Sequencing market.

Challenges2 items

Supply chain vulnerabilities—particularly for rare chemicals and consumables—pose risks to production continuity, with geopolitical tensions and raw material shortages increasing cost volatility.

Intense competition from both established players and agile startups is compressing profit margins, forcing providers to innovate rapidly or risk obsolescence in a market prioritizing speed-to-market and technical differentiation.

Market Segmentation

Loading chart…

Application Segmentation in the Sample Preparation Products for Next Generation Sequencing market is defined by downstream research and diagnostic use cases. The three primary subcategories—Genomics, Transcriptomics, and Epigenomics—reflect distinct biological analysis needs. Genomics dominates due to its foundational role in whole-genome sequencing and exome analysis, driving demand for high-throughput DNA extraction and library preparation tools. Transcriptomics, focused on RNA-based studies like gene expression profiling, benefits from specialized RNA isolation and cDNA synthesis kits. Epigenomics, though smaller, is growing rapidly as methylation and chromatin modification analyses gain clinical relevance. These applications collectively determine the market's revenue distribution, with Genomics accounting for ~45% of the Sample Preparation Products for Next Generation Sequencing segmentation.

Types Segmentation classifies products based on their functional role in the sample workflow. The two main categories are DNA Library Prep Kits and RNA Sample Prep Kits, each with subtypes addressing specific sample inputs (e.g., FFPE, plasma-derived DNA) and target applications (e.g., PCR-free vs. PCR-based amplification). DNA-based kits constitute the largest segment (~60% of the market taxonomy) due to their broad use in oncology and infectious disease research. RNA-focused solutions, while smaller, incorporate niche technologies like ribosomal RNA depletion and single-cell RNA sequencing reagents. Innovations in automation-compatible kits and multiplexed workflows further differentiate these types, influencing adoption rates across clinical and academic labs.

Sample Preparation Products for Next Generation Sequencing Segmentation Breakdown12 items

Application

Biotechnology

Medical

Pharmatheutical

Others

Types

DNA Extraction, Purification, and Isolation Products

RNA Extraction, Purification, and Isolation Products

Panels, Exome Kits, and Other Target Enrichment Products

DNA Library Construction/ Preparation Products

RNA-Seq, Transcriptome, and Gene Expression Products

Small RNA NGS Sample Preparation Products

Regional Insights

Loading chart…

The North America region dominates the Sample Preparation Products for Next Generation Sequencing market, holding a 40% value share, driven by advanced healthcare infrastructure, high adoption of genomic research, and robust R&D investments. The regional forecast highlights Europe as the second-largest market (25% share), supported by government-funded genomics initiatives and stringent regulatory frameworks promoting precision medicine. Asia Pacific (20% share) is emerging as the fastest-growing market, fueled by rising investments in biotechnology, expanding diagnostic laboratories, and a growing prevalence of genetic disorders. Latin America (10% share) and Middle East & Africa (5% share) exhibit slower growth but show potential due to improving healthcare access and public-private partnerships.

Key Regional Drivers5 items

North America: Advanced NGS adoption, ecosystem maturity, and high private-sector investment.

Europe: Policy-driven innovation, EU Horizon funding, and strong academic research networks.

Asia Pacific: Rising healthcare investments, demographic demand, and technology transfer agreements.

Latin America: Increasing public health funding and cross-border collaborations.

Middle East & Africa: Government-led healthcare modernization and rising chronic disease prevalence.

The Sample Preparation Products for Next Generation Sequencing market growth is projected to accelerate globally, with Asia Pacific leading in CAGR due to its scalable infrastructure development and cost-competitive manufacturing ecosystem.

Competitive Landscape

The Sample Preparation Products for Next Generation Sequencing market is moderately consolidated, with a mix of global leaders and niche players. Global manufacturers such as Thermo Fisher Scientific and Illumina dominate due to their extensive product portfolios and regulatory approvals, while regional firms like 10X Genomics and Qiagen compete through specialized offerings. Key competitive levers include Sample Preparation Products for Next Generation Sequencing key players leveraging differentiated technology platforms, strategic OEM partnerships, and compliance with evolving standards (e.g., ISO 13485). Pricing strategies vary, with premium segments driven by R&D investments and cost-sensitive markets prioritizing scalability.

Competitive differentiation centers on technology innovation (e.g., automation, miniaturization) and service ecosystems (e.g., bioinformatics integration). Common strategies include M&A activity to fill portfolio gaps, localized manufacturing to mitigate supply chain risks, and R&D focus on expanding application areas. However, margin pressures persist due to pricing competition in mature markets and rising R&D costs for next-gen technologies. Partnerships with academic institutions and diagnostics firms remain critical for validating new applications and securing reimbursement approvals.

10X Genomics: innovation pipeline for single-cell sequencing solutions

Agilent Technologies: OEM tie-ups for integrated NGS workflow systems

F. Hoffmann-La Roche AG: vertical integration to control production costs

Fluidigm: niche focus on low-input sample preparation tools

Illumina: premium pricing for high-throughput, high-accuracy kits

Qiagen: expansion of product portfolio via acquisitions

Key Sample Preparation Products for Next Generation Sequencing Companies10 items

10X Genomics

Agilent Technologies

F. Hoffmann-La Roche AG

Fluidigm

Illumina

New England Biolabs

Oxford Nanopore

Pacific Biosciences

Qiagen

Thermo Fisher Scientific

Market Ecosystem

The Sample Preparation Products for Next Generation Sequencing ecosystem spans upstream raw material suppliers, midstream manufacturers and integrators, and downstream end users, creating value through the development and delivery of tools that enable efficient genomic data generation. Value is captured through product sales, licensing, and service contracts, with dependencies on technological innovation and regulatory compliance.

Raw material/component suppliers – provide enzymes, reagents, and polymers for product development

OEMs / manufacturers – produce sample preparation kits, automation systems, and consumables

Technology providers – license sequencing platforms and software compatible with sample preparation workflows

System integrators – design customized solutions by combining products from multiple vendors

Distributors / channel partners – facilitate product access via direct sales and third-party networks

Service providers / after-sales – offer technical support, training, and maintenance for prepared samples

End users / buyers – academic, clinical, and biopharma labs utilizing sample prep for genomic analysis

Control points reside with OEMs and technology providers, which manage proprietary platforms and patents influencing adoption. Dependency risks include raw material shortages, stringent regulatory approvals, and interoperability constraints between vendors. High switching costs due to specialized workflows and partnerships reinforce ecosystem stability. Regional variations in standards and reimbursement policies further shape end-user purchasing behavior.

Recent Industry Insights

The Sample Preparation Products for Next Generation Sequencing (NGS) industry trends have been shaped by strategic collaborations and technological advancements over the past 18 months. Key players such as Thermo Fisher Scientific and Qiagen have expanded their market reach through partnerships with genomics research institutes, enhancing workflow integration for clinical and research applications. The sector also witnessed mergers & acquisitions, including PerkinElmer’s acquisition of a niche NGS sample prep startup, strengthening its automated solutions portfolio. Innovations in product/technology launches include AI-driven library prep kits and high-throughput automated systems from companies like Illumina and Beckman Coulter, addressing rising demand for precision medicine. Regulatory shifts, notably the FDA’s updated guidelines on NGS diagnostic validation, have spurred compliance-focused R&D. Meanwhile, enterprises are prioritizing cost-effective, scalable sample prep solutions, reflecting a broader industry push toward democratizing genomic research. Funding rounds totaling $120M in 2023 supported emerging firms specializing in single-cell sequencing prep tools, signaling confidence in next-gen technologies.

Analyst Overview

The Sample Preparation Products for Next Generation Sequencing market outlook remains highly attractive, driven by surging demand for precision medicine, expanding genomic research, and advancements in high-throughput sequencing technologies. Market growth is underpinned by increasing adoption of NGS in oncology, microbiomics, and liquid biopsy applications, creating robust opportunities for innovation and scalability.

Key Insights6 items

Market Attractiveness: High, with CAGR exceeding industry averages due to rising R&D investments and clinical diagnostics demand.

Competitive Intensity: Moderate to high, characterized by strategic collaborations, product differentiation, and market consolidation among key players like Thermo Fisher Scientific and Illumina.

Long-Term Outlook: Strong, supported by technological convergence with AI/ML for automated sample processing and expanding applications in rare disease research.

Innovation Landscape: Dynamic, with focus on miniaturization, single-cell sequencing readiness, and contamination-reducing workflows.

Demand-Supply Balance: Tight in emerging regions, necessitating localized manufacturing to address surging demand.

Key Risks: Regulatory bottlenecks, reimbursement uncertainties, and rapid obsolescence due to iterative tech advancements.

11 items

1. Executive Summary

2. Sample Preparation Products for Next Generation Sequencing Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Sample Preparation Products for Next Generation Sequencing Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Sample Preparation Products for Next Generation Sequencing Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Biotechnology

6.1.2. Medical

6.1.3. Pharmatheutical

6.1.4. Others

6.2. Global Sample Preparation Products for Next Generation Sequencing Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. DNA Extraction, Purification, and Isolation Products

6.2.2. RNA Extraction, Purification, and Isolation Products

6.2.3. Panels, Exome Kits, and Other Target Enrichment Products

6.2.4. DNA Library Construction/ Preparation Products

6.2.5. RNA-Seq, Transcriptome, and Gene Expression Products

6.2.6. Small RNA NGS Sample Preparation Products

6.3. Global Sample Preparation Products for Next Generation Sequencing Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Sample Preparation Products for Next Generation Sequencing Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Sample Preparation Products for Next Generation Sequencing Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Sample Preparation Products for Next Generation Sequencing Market Competition by Key Manufacturers

8.1. Global Sample Preparation Products for Next Generation Sequencing Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Sample Preparation Products for Next Generation Sequencing: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. 10X Genomics

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Agilent Technologies

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. F. Hoffmann-La Roche AG

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Fluidigm

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Illumina

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. New England Biolabs

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Oxford Nanopore

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Pacific Biosciences

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Qiagen

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Thermo Fisher Scientific

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Sample Preparation Products for Next Generation Sequencing Market

Figure 4: Global Sample Preparation Products for Next Generation Sequencing Market: Drivers

Figure 5: Global Sample Preparation Products for Next Generation Sequencing Market: Challenges

Figure 6: Global Sample Preparation Products for Next Generation Sequencing Market: Trends

Figure 7: Global Sample Preparation Products for Next Generation Sequencing Market: Opportunity

Figure 8: Global Sample Preparation Products for Next Generation Sequencing Market: Restraint

Figure 9: Global Sample Preparation Products for Next Generation Sequencing Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Sample Preparation Products for Next Generation Sequencing Market Value (USD Million) By Region

Figure 15: Global Sample Preparation Products for Next Generation Sequencing Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Sample Preparation Products for Next Generation Sequencing Market Value (USD Million) By Region

Figure 23: Global Sample Preparation Products for Next Generation Sequencing Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Sample Preparation Products for Next Generation Sequencing Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Sample Preparation Products for Next Generation Sequencing Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Sample Preparation Products for Next Generation Sequencing Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Sample Preparation Products for Next Generation Sequencing Market Value (USD Million) By Region

Table 10: Global Sample Preparation Products for Next Generation Sequencing Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Sample Preparation Products for Next Generation Sequencing Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Sample Preparation Products for Next Generation Sequencing Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Sample Preparation Products for Next Generation Sequencing Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: 10X Genomics Basic Information And Sales Area

Table 31: 10X Genomics. Products Portfolio

Table 32: Agilent Technologies Basic Information And Sales Area

Table 33: Agilent Technologies. Products Portfolio

Table 34: F. Hoffmann-La Roche AG Basic Information And Sales Area

Table 35: F. Hoffmann-La Roche AG. Products Portfolio

Table 36: Fluidigm Basic Information And Sales Area

Table 37: Fluidigm. Products Portfolio

Table 38: Illumina Basic Information And Sales Area

Table 39: Illumina. Products Portfolio

Table 40: New England Biolabs Basic Information And Sales Area

Table 41: New England Biolabs. Products Portfolio

Table 42: Oxford Nanopore Basic Information And Sales Area

Table 43: Oxford Nanopore. Products Portfolio

Table 44: Pacific Biosciences Basic Information And Sales Area

Table 45: Pacific Biosciences. Products Portfolio

Table 46: Qiagen Basic Information And Sales Area

Table 47: Qiagen. Products Portfolio

Table 48: Thermo Fisher Scientific Basic Information And Sales Area

Table 49: Thermo Fisher Scientific. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Sample Preparation Products for Next Generation Sequencing Market Value (USD Million) By Region

Table 55: Global Sample Preparation Products for Next Generation Sequencing Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Sample Preparation Products for Next Generation Sequencing Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	3.20 billion
Revenue forecast in 2033	8.39 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	10X Genomics; Agilent Technologies; F. Hoffmann-La Roche AG; Fluidigm; Illumina; New England Biolabs; Oxford Nanopore; Pacific Biosciences; Qiagen; Thermo Fisher Scientific
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options